Effects of dopexamine on acute necrotising pancreatitis in rats

European Journal of Surgery

Volumn 167, Issue 10, 2001, Pages 761-766

  Alhan, E ^a   Kucuktulu U ^a   Ercin C ^a   Deger, O ^a   Cicek R ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Acute pancreatitis; Dopexamine; Pancreatic tissue oxygen pressure; Trypsinogen activation peptide

Indexed keywords

AMYLASE; DOPEXAMINE; TRYPSINOGEN ACTIVATION PEPTIDE;

ACINAR CELL; ACUTE HEMORRHAGIC PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN TISSUE LEVEL; PANCREAS BLOOD FLOW; PRIORITY JOURNAL; RAT;

AMYLASES; ANIMALS; BLOOD GAS ANALYSIS; CAERULEIN; DISEASE MODELS, ANIMAL; DOPAMINE; HEMODYNAMIC PROCESSES; MALE; MICROCIRCULATION; OXYGEN CONSUMPTION; PANCREAS; PANCREATITIS, ACUTE NECROTIZING; PROBABILITY; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 0035663404     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/11024150152707743     Document Type: Article

References (33)

1. Does pancreatic necrosis predict severity inpatients with acute necrotizing pancreatitis?
2. 2 after administration of anti-TNF antibody in patients with severe sepsis: Comparison of interleukin-6 serum levels, APACHE II, and Elebute scores
3. Dopexamine a novel agonist at peripheral dopamine receptors and beta 2 hormones and drugs on canine pancreatic blood flow
4. Influences of adrenoreceptors
5. Acute hemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist in patient with chronic heart failure
6. Debridement and closed packing for the treatment of necrotizing pancreatitis
7. Effects of microcirculatory perfusion on distribution of trypsinogen activation peptides in acute experimental pancreatitis
8. Endothelin receptor blockade in severe acute pancreatitis leads to systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates
9. The use of dopexamine after cardiac surgery: Acute and long term effects in patients with impaired cardiac function
10. Trypsinogen activation peptides assays in the early prediction of severity of acute pancreatitis
11. Pancreatic ischemia in experimental acute pancreatitis: Mechanism, significance and therapy
12. Microcirculation of the pancreas: A quantitative study of physiology and changes in pancreatitis
13. Improvements of impaired pancreatic microcirculation by isovolemic hemodilution protects pancreatic morphology in acute biliary pancreatitis
14. Pancreatic microcirculatory changes in experimental pancreatitis of graded severity in the rat
15. Regional blood flow responses to vasodilators and inotropes in congestive heart failure
16. Human renovascular effects of dopexamine hydrochloride: A novel agonist of dopamine and beta 2 adreno-receptors
17. Increasing splanchnic blood flow in the critically ill
18. Increased intrapancreatic trypsinogen activation in ischemia induced experimental pancreatitis
19. The differing effects of dopexamine, dobutamine and placebo on the histology of liver in pig peritonitis
20. Assessments of liver microcirculation with the multiple indicator technique
21. Early effects of cathecholamine therapy on mucosal integrity, intestinal blood flow, and oxygen metabolism in porcine endotoxine shock
22. A better model of acute pancreatitis for evaluating therapy
23. Morphometric characteristics and homogeneity of a new model of acute pancreatitis in the rat
24. Trypsinogen activation peptides in experimental rat pancreatitis: Prognostic implication and histopathologic correlates
25. Frequency and time course of pancreatic and extrapancreatic bacterial infection in experimental pancreatitis, in rats
26. An introduction to the pharmocologic properties of dopexamine
27. Dopexamine hydrochloride: A novel dopamine receptor agonist for the acute treatment of low cardiac output states
28. Etiology and pathophysiology of acute pancreatitis
29. Secretory and vascular responses to various biogenic and foreign substances of the perfused canine pancreas
30. Effects of cathecholamines and their inhibitors on the isolated canine pancreas
31. Vasoactive mediators and the progression from oedematous to necrotising experimental acute pancreatitis
32. Role of pancreatic blood flow and vasoactive substances in the development of canine acute pancreatitis
33. The effects of prostaglandin E1 on the microperfusion of the pancreas during acute pancreatitis